Improved characterization of the pharmacokinetics of acalabrutinib and its pharmacologically active metabolite, ACP‐5862, in patients with B‐cell malignancies and in healthy subjec...

por Edlund, Helena, Bellanti, Francesco, Liu, Huan, Vishwanathan, Karthick, Tomkinson, Helen, Ware, Joseph, Sharma, Shringi, Buil‐Bruna, Núria
Publicado 2021

Exposure–response analysis of acalabrutinib and its active metabolite, ACP‐5862, in patients with B‐cell malignancies

por Edlund, Helena, Buil‐Bruna, Núria, Vishwanathan, Karthick, Wei, Helen, Raman, Rakesh, de Kock, Miné, He, Zhongqing, Liu, Huan, Baek, Marshall, Ware, Joseph, Patel, Priti, Tomkinson, Helen, Sharma, Shringi
Publicado 2021